The JITC Editorial Board is comprised of approximately 100 experienced researchers and clinicians from around the globe. These editors not only handle the peer review for submitted manuscripts, but they also oversee special projects and teams – such as the Social Media Team – that help to advance the reach of author publications.
Get to know JITC’s Founding Editor-in-Chief Pedro J. Romero, MD as he met with 2021-2022 SITC President Patrick Hwu, MD during a SITC Fireside Chat in 2021.
Meet JITC’s Interim Editor-in-Chief (then Deputy Editor-in Chief) James L. Gulley, MD, PhD, FACP
On a monthly basis, SITC’s global network receives news on the latest JITC publications, complete with editor-selected summaries highlighting the importance and implications of key articles. Sign up to have the JITC Digest sent to your inbox each month, or explore the JITC Digest Archives.
To provide readers with a well-rounded view of research in tumor immunology and cancer immunotherapy, each month’s featured JITC editor shares a reading list of key publications in other journals that pique their interest and add value to what readers may find in JITC.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com